Related Experiment Video
Updated: Jun 24, 2026

Antibiotic Dereplication Using the Antibiotic Resistance Platform
Published on: October 17, 2019
Structure revision of the lantibiotic 97518
Sonia I Maffioli1, Donatella Potenza, Francesca Vasile
1NAICONS, New Anti-Infective CONSortium, Milan, Italy. SMaffioli@naicons.com
Abstract:
The lantibiotic 97518, produced by a Planomonospora sp., was reported as a 2194 Da polypeptide comprising 24 amino acid residues with five thioether bridges. It was assigned to the mersacidin subgroup of type B lantibiotics by Castiglione et al. (Biochemistry 2007, 46, 5884-5897) and named planosporicin. New analytical, chemical, and genetic data and reinterpretation of the published NMR chemical shifts enable structure revision of 97518. The resulting revision of the 97518 structure involves both a shift of two amino acids and a reorganization of two thioether bridges. With this revision, the lantibiotic 97518 becomes a clear member of the nisin subgroup of compounds.
Related Concept Videos
Production of Antibiotics
Development of Antibiotic Resistance
Antibiotic Selection
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Production of Pharmaceuticals

